AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $12.6M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$12.6M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 4 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $186.51
- 52-wk high
- $260.19
- High
- $188.00
- 52-wk low
- $117.30
- Low
- $184.00
- Prev close
- $186.14
- Mkt cap
- $10.16B
- Volume
- 1.03M
- Fwd P/E
- 32.1x
- Beta
- 0.71
- P/S
- 13.1x
- P/B
- 121.6x
- Profit margin
- -24.7%
- Op margin
- -23.4%
- ROE
- -245.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about AXSM filings
Are insiders buying or selling Axsome Therapeutics Inc (AXSM) stock?
Net selling: insiders sold $12.6M and bought $0 of AXSM stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $12.6M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Tabuteau, Herriot (Chief Executive Officer), who sold $10.5M. The latest filing was on Sep 3, 2026.
Which members of Congress have traded AXSM recently?
None. No member of Congress disclosed a AXSM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this AXSM smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- MI
Millennium
$132.6M
added
- TS
Two Sigma
$109.3M
added
- JS
Jim Simons
$36.4M
added
What insiders are doing
Sells (3)
- JM
Jacobson Mark L.
$2.1M
sold
- TH
Tabuteau Herriot
$10.5M
sold
- TH
Tabuteau Herriot
$11.9M
sold
How top traders are positioned
No tracked top-trader positions in AXSM right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
-$0.99 expected
Reports Nov 2, 2026, in 32 days
Estimates as of Oct 1, 2026
EPS expected
-$1.00 to -$0.03
Revenue expected
20 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $171.0M | $196.0M | $191.2M | $218.4M |
| Cost of what it sold | $11.9M | $12.3M | $14.7M | $13.6M |
| Gross profit | $159.1M | $183.7M | $176.5M | $204.8M |
| What it spent | ||||
| Research and development | $40.2M | $48.8M | $52.7M | $46.2M |
| Sales and admin | $108.8M | $169.3M | $185.0M | $208.1M |
| Other operating costs | $56.2M | -$5.0M | — | — |
| Total operating expenses | $205.2M | $213.1M | $239.8M | $254.5M |
| What was left | ||||
| Operating profit | -$46.1M | -$29.4M | -$63.4M | -$49.6M |
| Interest on debt | $1.1M | $1.2M | $1.2M | $1.5M |
| Profit before tax | -$47.2M | -$28.1M | -$64.5M | -$51.2M |
| Tax | — | $430.0K | — | $128.0K |
| Net profit | -$47.2M | -$28.6M | -$64.5M | -$51.3M |
| EBITDA | -$44.4M | -$24.7M | -$61.1M | -$49.6M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace